16:23 EDT UroGen Pharma files to sell 12.58M ordinary shares for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on URGN:
- TD Cowen biotech analyst to hold an analyst/industry conference call
- UroGen Pharma sees FY23 JELMYTO revenue $76M-$86M
- UroGen Pharma reports Q2 EPS ($1.03) vs. ($1.18) last year
- URGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- ‘Opportunities Outweigh Risks’: Oppenheimer Sees at Least 60% Gains in These 2 Stocks